247 related articles for article (PubMed ID: 36445642)
21. Dosimetric comparison of inverse optimisation methods versus forward optimisation in HDR brachytherapy of breast, cervical and prostate cancer.
Fröhlich G; Geszti G; Vízkeleti J; Ágoston P; Polgár C; Major T
Strahlenther Onkol; 2019 Nov; 195(11):991-1000. PubMed ID: 31482321
[TBL] [Abstract][Full Text] [Related]
22. Status of head and neck brachytherapy in Spain in 2022.
Guinot JL; Diezhandino P; de Frutos JM; Fuentemilla N; Gonzalez-Perez V; Gutierrez C; Herreros A; Martinez-Monge R; Perez-Echagüen S; Pino F; Roldán S; Rovirosa A; Santos MA; Sanz-Freire CJ; Villafranca E
Clin Transl Oncol; 2024 Feb; 26(2):456-460. PubMed ID: 37548869
[TBL] [Abstract][Full Text] [Related]
23. The Vienna applicator for combined intracavitary and interstitial brachytherapy of cervical cancer: design, application, treatment planning, and dosimetric results.
Kirisits C; Lang S; Dimopoulos J; Berger D; Georg D; Pötter R
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):624-30. PubMed ID: 16690444
[TBL] [Abstract][Full Text] [Related]
24. Magnetic resonance imaging (MRI) markers for MRI-guided high-dose-rate brachytherapy: novel marker-flange for cervical cancer and marker catheters for prostate cancer.
Schindel J; Muruganandham M; Pigge FC; Anderson J; Kim Y
Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):387-93. PubMed ID: 23433797
[TBL] [Abstract][Full Text] [Related]
25. Patient-specific cylinder templates for hybrid interstitial vaginal brachytherapy: Feasibility of automated 3-D design, 3D printing, and dosimetric outlook.
Kudla M; Bachand F; Moore J; Batchelar D
Brachytherapy; 2023; 22(4):468-476. PubMed ID: 37169607
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of an MR-only interstitial gynecologic brachytherapy workflow using MR-line marker for catheter reconstruction.
Shaaer A; Paudel M; Smith M; Tonolete F; Nicolae A; Leung E; Ravi A
Brachytherapy; 2020; 19(5):642-650. PubMed ID: 32712027
[TBL] [Abstract][Full Text] [Related]
27. Catheter reconstruction and dosimetric verification of MRI-only treatment planning (MRTP) for interstitial HDR brachytherapy using PETRA sequence.
Lee CY; Kaza E; Harris TC; O'Farrell DA; King MT; Dyer MA; Cormack RA; Buzurovic I
Phys Med Biol; 2023 Jan; 68(3):. PubMed ID: 36584396
[No Abstract] [Full Text] [Related]
28. Dosimetric impact of contouring and needle reconstruction uncertainties in US-, CT- and MRI-based high-dose-rate prostate brachytherapy treatment planning.
Rylander S; Buus S; Pedersen EM; Bentzen L; Tanderup K
Radiother Oncol; 2017 Apr; 123(1):125-132. PubMed ID: 28284493
[TBL] [Abstract][Full Text] [Related]
29. Image-guided brachytherapy for cervical cancer: a Canadian Brachytherapy Group survey.
Pavamani S; D'Souza DP; Portelance L; Craighead PS; Pearce AG; Traptow LL; Doll CM
Brachytherapy; 2011; 10(5):345-51. PubMed ID: 21345744
[TBL] [Abstract][Full Text] [Related]
30. The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the endometrium.
Nag S; Erickson B; Parikh S; Gupta N; Varia M; Glasgow G
Int J Radiat Oncol Biol Phys; 2000 Oct; 48(3):779-90. PubMed ID: 11020575
[TBL] [Abstract][Full Text] [Related]
31. Computed Tomography-Guided Interstitial Brachytherapy for Locally Advanced Cervical Cancer: Introduction of the Technique and a Comparison of Dosimetry With Conventional Intracavitary Brachytherapy.
Liu ZS; Guo J; Zhao YZ; Lin X; Zhang BY; Zhang C; Wang HY; Yu L; Ren XJ; Wang TJ
Int J Gynecol Cancer; 2017 May; 27(4):768-775. PubMed ID: 28267131
[TBL] [Abstract][Full Text] [Related]
32. Proof of principle: Applicator-guided stereotactic IMRT boost in combination with 3D MRI-based brachytherapy in locally advanced cervical cancer.
Assenholt MS; Vestergaard A; Kallehauge JF; Mohamed S; Nielsen SK; Petersen JB; Fokdal L; Lindegaard JC; Tanderup K
Brachytherapy; 2014; 13(4):361-8. PubMed ID: 24656732
[TBL] [Abstract][Full Text] [Related]
33. Three-dimensional-guided perineal-based interstitial brachytherapy in cervical cancer: A systematic review of technique, local control and toxicities.
Mendez LC; Weiss Y; D'Souza D; Ravi A; Barbera L; Leung E
Radiother Oncol; 2017 May; 123(2):312-318. PubMed ID: 28351521
[TBL] [Abstract][Full Text] [Related]
34. Image-based multichannel vaginal cylinder brachytherapy for the definitive treatment of gynecologic malignancies in the vagina.
Gebhardt BJ; Vargo JA; Kim H; Houser CJ; Glaser SM; Sukumvanich P; Olawaiye AB; Kelley JL; Edwards RP; Comerci JT; Courtney-Brooks M; Beriwal S
Gynecol Oncol; 2018 Aug; 150(2):293-299. PubMed ID: 29929925
[TBL] [Abstract][Full Text] [Related]
35. Outcomes of 3D MRI based HDR brachytherapy with hybrid multichannel vaginal cylinder applicator and freehand needles for treatment of vaginal disease.
Mulherkar R; Keller A; Houser CJ; Kim H; Doraisamy E; Baig T; Barry P; Vargo JA; Beriwal S
Brachytherapy; 2023; 22(1):66-71. PubMed ID: 36266203
[TBL] [Abstract][Full Text] [Related]
36. Interstitial High-Dose-Rate Gynecologic Brachytherapy: Clinical Workflow Experience From Three Academic Institutions.
Prisciandaro JI; Zhao X; Dieterich S; Hasan Y; Jolly S; Al-Hallaq HA
Semin Radiat Oncol; 2020 Jan; 30(1):29-38. PubMed ID: 31727297
[TBL] [Abstract][Full Text] [Related]
37. Image-guided preplanning workflow for high-dose-rate interstitial brachytherapy for gynecological malignancies.
Huang YJ; DeCesaris CM; Sarkar V; Zhao H; Kunz J; Nelson G; Li X; Suneja G; Burt LM; Gaffney DK
Brachytherapy; 2024; 23(1):25-34. PubMed ID: 37777394
[TBL] [Abstract][Full Text] [Related]
38. [High-dose gynecologic endocavitary brachytherapy. Technical and dosimetric aspects].
Grillo Ruggieri F; Parietti E; Bistolfi F; Tomassini E; Papadia S; Leonardi S; Siragusa A; Guglielmi M; Brizzi C; Scielzo G
Radiol Med; 1989 Oct; 78(4):373-9. PubMed ID: 2595028
[TBL] [Abstract][Full Text] [Related]
39. The implementation of the Gynaecological Groupe Européen de Curiethérapie - European Society for Therapeutic Radiology and Oncology radiobiology considerations in the conversion of low dose rate to pulsed dose rate treatment schedules for gynaecological brachytherapy.
Baker S; Pooler A; Hendry J; Davidson S
Clin Oncol (R Coll Radiol); 2013 Apr; 25(4):265-71. PubMed ID: 23218875
[TBL] [Abstract][Full Text] [Related]
40. Computed tomography-planned interstitial brachytherapy for locally advanced gynecologic cancer: Outcomes and dosimetric predictors of urinary toxicity.
Amsbaugh MJ; Bhatt N; Hunter T; Gaskins J; Parker L; Metzinger D; Amsbaugh A; Sowards K; El-Ghamry MN
Brachytherapy; 2016; 15(1):49-56. PubMed ID: 26614237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
